{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:45:16Z","timestamp":1788291916672,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21502166"],"award-info":[{"award-number":["21502166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbagen.2023.130362","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:09:10Z","timestamp":1680912550000},"page":"130362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer"],"prefix":"10.1016","volume":"1867","author":[{"given":"Xing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbagen.2023.130362_bb0005","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1021\/bm400406x","article-title":"Carboxymethyl-chitosan-tethered lipid vesicles: hybrid Nanoblanket for Oral delivery of paclitaxel","volume":"14","author":"Joshi","year":"2013","journal-title":"Biomacromolecules"},{"issue":"21","key":"10.1016\/j.bbagen.2023.130362_bb0010","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1021\/jacs.5b04944","article-title":"Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers","volume":"137","author":"Zhang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130362_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0968-0896(99)00301-6","article-title":"Paclitaxel esters of malic acid as prodrugs with improved water solubility","volume":"8","author":"Damen","year":"2000","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2009.09.023","article-title":"pH-sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles","volume":"142","author":"Chen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2023.130362_bb0025","unstructured":"S. Shaik, G.D. Kumar, V.V. Naik, A. Rajesh, Nano Technol. Ocular Drug Deliv."},{"issue":"11","key":"10.1016\/j.bbagen.2023.130362_bb0030","first-page":"2002","volume":"53","author":"Jain","year":"2007","journal-title":"Appl. Nanobiotechnol. Clin. Diagnos."},{"issue":"10","key":"10.1016\/j.bbagen.2023.130362_bb0035","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/nl502044x","article-title":"Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines","volume":"14","author":"Wang","year":"2014","journal-title":"Nano Lett."},{"issue":"5709","key":"10.1016\/j.bbagen.2023.130362_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1126\/science.1104274","article-title":"Quantum dots for live cells, in vivo imaging, and diagnostics","volume":"307","author":"Michalet","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2023.130362_bb0045","series-title":"Reducing Hydrophobicity of Homogeneous Antibody-drug Conjugates Improves Pharmacokinetics and Therapeutic Index","author":"Lyon","year":"2015"},{"key":"10.1016\/j.bbagen.2023.130362_bb0050","article-title":"Clinical translation of nanomedicine","volume":"11147","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"issue":"46","key":"10.1016\/j.bbagen.2023.130362_bb0055","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2011.05.082","article-title":"Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes","volume":"416","author":"Patel","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130362_bb0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/mp2002736","article-title":"Paclitaxel\/Tetrandrine Coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on \u201coxidation therapy\u201d","volume":"9","author":"Li","year":"2012","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.bbagen.2023.130362_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-003-0742-5","article-title":"Pharmacology, characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance","volume":"53","author":"Fu","year":"2004","journal-title":"Cancer Chemother."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130362_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-8741(02)00082-X","article-title":"Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells","volume":"81","author":"Yoo","year":"2002","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0085","article-title":"Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation","volume":"3","author":"Z.D","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"issue":"26","key":"10.1016\/j.bbagen.2023.130362_bb0090","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2023.130362_bb0095","doi-asserted-by":"crossref","first-page":"46057","DOI":"10.1038\/srep46057","article-title":"Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2023.130362_bb0100","article-title":"Reduction-sensitive paclitaxel prodrug self-assembled nanoparticles with Tetrandrine effectively promote synergistic therapy against drug-sensitive and multidrug-resistant breast cancer","volume":"3628","author":"Jiang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bbagen.2023.130362_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U","article-title":"Glutathione levels and variability in breast tumors and normal tissue","volume":"72","author":"Perry","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.bbagen.2023.130362_bb0110","first-page":"23","article-title":"Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma","author":"Shi Liu","year":"2017","journal-title":"J. Control. Rel. Off. J. Control. Rel. Soc. 254"},{"issue":"46","key":"10.1016\/j.bbagen.2023.130362_bb0115","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem."},{"issue":"28","key":"10.1016\/j.bbagen.2023.130362_bb0120","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1002\/ange.201301397","article-title":"Synthesis of paclitaxel-conjugated \u03b2-cyclodextrin polyrotaxane and its antitumor activity","volume":"125","author":"Shuling","year":"2013","journal-title":"Angew. Chem."},{"issue":"31","key":"10.1016\/j.bbagen.2023.130362_bb0125","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1002\/adma.201501803","article-title":"Therapeutic enzyme-responsive nanoparticles for targeted delivery and accumulation in tumors","volume":"27","author":"Callmann","year":"2015","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.bbagen.2023.130362_bb0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2010.07.123","article-title":"A simple method to achieve high doxorubicin loading in biodegradable polymersomes","volume":"147","author":"Sanson","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2023.130362_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201502022","article-title":"Nanoparticle-loaded protein\u2013polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery","volume":"27","author":"Lee","year":"2015","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0140","first-page":"213","article-title":"Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy","volume":"15","author":"Dawei","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.bbagen.2023.130362_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","article-title":"Poly(ethylene oxide)\u2013poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs","volume":"66","author":"Chiappetta","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbagen.2023.130362_bb0150","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.bbagen.2023.130362_bb0155","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/sj.onc.1202211","article-title":"Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases","volume":"17","author":"Higuchi","year":"1998","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.bbagen.2023.130362_bb0160","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1158\/0008-5472.CAN-08-2010","article-title":"The Thioredoxin system mediates redox-induced cell death in human Colon cancer cells: implications for the mechanism of action of anticancer agents","volume":"68","author":"Sun","year":"2008","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.bbagen.2023.130362_bb0165","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0024-3205(02)01989-6","article-title":"Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in neuro 2a mouse neuroblastoma cells","volume":"71","author":"Jin","year":"2002","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bbagen.2023.130362_bb0170","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bcp.2004.01.018","article-title":"Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-\u03b4 in U937 cells","volume":"67","author":"Jang","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2023.130362_bb0175","doi-asserted-by":"crossref","unstructured":"B. Ramanathan, K.Y. Jan, C.H. Chen, T.C. Hour, Y.S. Pu, Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, Pu YS Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 65: 8455\u20138460.","DOI":"10.1158\/0008-5472.CAN-05-1162"},{"issue":"8","key":"10.1016\/j.bbagen.2023.130362_bb0180","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1166\/jbn.2014.1846","article-title":"Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy","volume":"10","author":"Li","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"issue":"9","key":"10.1016\/j.bbagen.2023.130362_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130362_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2012.05.051","article-title":"Nanotechnology applied to overcome tumor drug resistance","volume":"162","author":"Gao","year":"2012","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.bbagen.2023.130362_bb0195","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00432-009-0704-3","article-title":"Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription","volume":"136","author":"Shen","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bbagen.2023.130362_bb0200","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1021\/ja513034e","article-title":"Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency","volume":"137","author":"Kaimin","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bbagen.2023.130362_bb0205","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/nl502044x","article-title":"Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines","volume":"14","year":"2014","journal-title":"Nano Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:03:02Z","timestamp":1736348582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416523000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0304416523000600"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130362","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130362"}}